New urine test could spot bladder cancer when others Can't

NCT ID NCT06870253

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a new urine test called Bladder CARE™ to see if it can detect bladder cancer in people whose standard tests (cystoscopy or cytology) gave unclear results. About 80 adults with suspicious but inconclusive findings will provide a urine sample before their routine cystoscopy. Researchers will then check how well the test performs compared to standard diagnostic methods, with follow-up at 6 and 12 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Bladder CARE™ Assay (urine-based diagnostic test)
What this could lead to
If successful, this test could provide a non-invasive way to diagnose bladder cancer when standard methods are inconclusive, reducing the need for invasive procedures.
What could go wrong
This is an early observational study with only 80 participants, so results may not apply to everyone. The test may not be accurate enough to replace current methods.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Mayo Clinic

    Rochester, Minnesota, 55905, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.